Clinical trial
A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia…
NCT00038415 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00038415 |
|---|---|
| Title | A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach |
| Official title | A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphocytic, Chronic |
| Intervention type | Biological |
| Interventions | CLL vaccine using DNA plasmid vector |
| Enrollment | 2 |
| Start date | Dec 1, 2001 |
| Primary completion | Jul 1, 2004 |
| Completion | Jan 1, 2005 |
| First posted | May 31, 2002 |
| Last update posted | Oct 31, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: